Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
IJPR-Iranian Journal of Pharmaceutical Research. 2017; 16 (1): 22-34
en Inglés | IMEMR | ID: emr-187945

RESUMEN

Ketotifen fumarate is a non-bronchodilator anti-asthmatic drug which inhibits the effects of certain endogenous substances known to be inflammatory mediators, and thereby exerts antiallergic activity. The present study describes the formulation of a sustained release nanoparticle [NP] drug delivery system containing ketoftifen, using poly [D,L lactide-co-glycolide] acid [PLGA]. Biodegradable NPs were prepared using 50: 50 PLGA by a water in-oil-in-water [w/o/w] double emulsion-solvent evaporation procedure and characterized for drug content, DSC [differential scanning calorimetry, XRD [X-ray diffractionl], FTIR [Fourier transform spectroscopy], particle size, surface morphology using scanning electron microscopy, and drug release rate. The effects of different drug-to-polymer ratios on the characteristics of the NPs were investigated. NPs prepared were spherical with a smooth surface. Size of NPs was dependent on the concentration of polymer [10 mg/mL, 754.6 nm]. Increasing the external organic phase volume [primary emulsion] resulted in larger particles with higher encapsulation efficiency [55%]. The best drug to polymer ratio in the NP was F[3] [1:10 ratio] which showed loading efficiency of 55%, and mean particle size of 754.6 nm, respectively. The FTIR, XRPD, and DSC results ruled out any chemical interaction between the drug and PLGA. The NPs prepared with low ratio of drug to polymer [1:5] F[1] formulation showed faster dissolution rate than those with high drug to polymer ratio [1:10] F[3] formulation. In conclusion, by selecting an appropriate level of the investigated parameters, spherical NPs with encapsulation efficiencies higher than 55% and a prolonged drug release over 24h [73.67-90.05%] were obtained

2.
DARU-Journal of Faculty of Pharmacy Tehran University of Medical Sciences. 2005; 13 (4): 37-45
en Inglés | IMEMR | ID: emr-70330

RESUMEN

Solubility of sulphamethoxazole, sulphisoxazole and sulphasalazine in six solvents namely water,methanol, ethanol, 1-propanol, acetone and chloroform were determined at 15, 25, 37 and 45 °C. Two models derived from the Hildebrand solubility approach are proposed for solubility prediction at different temperatures using a single determination. The experimental data of the present work as well as data gathered from the literature have been employed to investigate the accuracy and prediction capability of the proposed models. The overall percent deviations between the predicted and experimental values were 10.78 and 14.63% which were comparable to those of the classical two and three parameter models. The proposed models were much superior to the two pure predictive models i.e., the ones which do not require experimental solubility determination, as the overall percent deviations produced by the latter models were 150.09 and 161.00%


Asunto(s)
Sulfonamidas/farmacología , Solubilidad , Predicción , Temperatura , Diseño de Fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA